vs
合众银行(CUBI)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是REPLIGEN CORP的1.2倍($236.9M vs $197.9M),合众银行同比增速更快(21.8% vs 13.6%),合众银行自由现金流更多($481.0M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 14.2%)
合众银行是总部位于美国明尼苏达州明尼阿波利斯、在特拉华州注册的跨国银行机构,2025年位列美国第五大银行,也是美国中西部规模最大的银行,被金融稳定委员会认定为具有系统重要性。旗下核心运营主体为美国合众银行全国协会,提供银行、投资、按揭等多元金融服务。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
CUBI vs RGEN — 直观对比
营收规模更大
CUBI
是对方的1.2倍
$197.9M
营收增速更快
CUBI
高出8.2%
13.6%
自由现金流更多
CUBI
多$463.5M
$17.6M
两年增速更快
RGEN
近两年复合增速
14.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $236.9M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 41.1% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 21.8% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益(稀释后) | $2.04 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CUBI
RGEN
| Q4 25 | $236.9M | $197.9M | ||
| Q3 25 | $232.1M | $188.8M | ||
| Q2 25 | $206.3M | $182.4M | ||
| Q1 25 | $143.0M | $169.2M | ||
| Q4 24 | $167.8M | $174.1M | ||
| Q3 24 | $167.1M | $154.9M | ||
| Q2 24 | $198.7M | $154.1M | ||
| Q1 24 | $181.6M | $151.3M |
净利润
CUBI
RGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $75.7M | $14.9M | ||
| Q2 25 | $60.9M | $14.9M | ||
| Q1 25 | $12.9M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $46.7M | $-654.0K | ||
| Q2 24 | $58.1M | $3.3M | ||
| Q1 24 | $49.7M | $2.1M |
毛利率
CUBI
RGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率
CUBI
RGEN
| Q4 25 | 41.1% | 9.0% | ||
| Q3 25 | 43.2% | 8.9% | ||
| Q2 25 | 38.2% | 7.6% | ||
| Q1 25 | 8.3% | 3.9% | ||
| Q4 24 | 21.4% | -17.7% | ||
| Q3 24 | 27.5% | -5.1% | ||
| Q2 24 | 38.8% | 1.0% | ||
| Q1 24 | 36.0% | 1.3% |
净利率
CUBI
RGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 32.6% | 7.9% | ||
| Q2 25 | 29.5% | 8.2% | ||
| Q1 25 | 9.0% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 28.0% | -0.4% | ||
| Q2 24 | 29.2% | 2.2% | ||
| Q1 24 | 27.4% | 1.4% |
每股收益(稀释后)
CUBI
RGEN
| Q4 25 | $2.04 | $0.24 | ||
| Q3 25 | $2.20 | $0.26 | ||
| Q2 25 | $1.73 | $0.26 | ||
| Q1 25 | $0.29 | $0.10 | ||
| Q4 24 | $0.72 | $-0.55 | ||
| Q3 24 | $1.31 | $-0.01 | ||
| Q2 24 | $1.66 | $0.06 | ||
| Q1 24 | $1.40 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.4B | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $2.1B | $2.1B |
| 总资产 | $24.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
CUBI
RGEN
| Q4 25 | $4.4B | $767.6M | ||
| Q3 25 | $4.2B | $748.7M | ||
| Q2 25 | $3.5B | $708.9M | ||
| Q1 25 | $3.4B | $697.2M | ||
| Q4 24 | $3.8B | $757.4M | ||
| Q3 24 | $3.1B | $784.0M | ||
| Q2 24 | $3.0B | $809.1M | ||
| Q1 24 | $3.7B | $780.6M |
总债务
CUBI
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
CUBI
RGEN
| Q4 25 | $2.1B | $2.1B | ||
| Q3 25 | $2.1B | $2.1B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $1.8B | $2.0B | ||
| Q3 24 | $1.8B | $2.0B | ||
| Q2 24 | $1.7B | $2.0B | ||
| Q1 24 | $1.7B | $2.0B |
总资产
CUBI
RGEN
| Q4 25 | $24.9B | $2.9B | ||
| Q3 25 | $24.3B | $2.9B | ||
| Q2 25 | $22.6B | $2.9B | ||
| Q1 25 | $22.4B | $2.9B | ||
| Q4 24 | $22.3B | $2.8B | ||
| Q3 24 | $21.5B | $2.8B | ||
| Q2 24 | $20.9B | $2.9B | ||
| Q1 24 | $21.3B | $2.8B |
负债/权益比
CUBI
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $494.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $481.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 203.0% | 8.9% |
| 资本支出强度资本支出/营收 | 5.8% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $843.0M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
CUBI
RGEN
| Q4 25 | $494.8M | $25.7M | ||
| Q3 25 | $116.9M | $48.1M | ||
| Q2 25 | $162.2M | $28.6M | ||
| Q1 25 | $94.1M | $15.0M | ||
| Q4 24 | $145.1M | $39.2M | ||
| Q3 24 | $24.4M | $49.3M | ||
| Q2 24 | $6.1M | $42.2M | ||
| Q1 24 | $-18.8M | $44.7M |
自由现金流
CUBI
RGEN
| Q4 25 | $481.0M | $17.6M | ||
| Q3 25 | $106.4M | $43.4M | ||
| Q2 25 | $162.1M | $21.5M | ||
| Q1 25 | $93.4M | $11.4M | ||
| Q4 24 | $143.6M | $33.6M | ||
| Q3 24 | $24.1M | $42.3M | ||
| Q2 24 | $5.8M | $37.4M | ||
| Q1 24 | $-19.2M | $36.4M |
自由现金流率
CUBI
RGEN
| Q4 25 | 203.0% | 8.9% | ||
| Q3 25 | 45.9% | 23.0% | ||
| Q2 25 | 78.6% | 11.8% | ||
| Q1 25 | 65.4% | 6.8% | ||
| Q4 24 | 85.5% | 19.3% | ||
| Q3 24 | 14.4% | 27.3% | ||
| Q2 24 | 2.9% | 24.3% | ||
| Q1 24 | -10.6% | 24.0% |
资本支出强度
CUBI
RGEN
| Q4 25 | 5.8% | 4.1% | ||
| Q3 25 | 4.5% | 2.5% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 0.9% | 3.2% | ||
| Q3 24 | 0.2% | 4.5% | ||
| Q2 24 | 0.2% | 3.1% | ||
| Q1 24 | 0.2% | 5.5% |
现金转化率
CUBI
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.54× | 3.23× | ||
| Q2 25 | 2.66× | 1.92× | ||
| Q1 25 | 7.29× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.52× | — | ||
| Q2 24 | 0.10× | 12.70× | ||
| Q1 24 | -0.38× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图